191
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:April 18, 2018Completed
Refractory Multiple Myeloma: 1441 Clinical Trials, Page 20 of 145
Hide Studies Not Open or Pending
192
Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:November 21, 2019Terminated
193
Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:November 1, 2016Completed
194
RMPT for Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:May 10, 2016Completed
195
Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple Myeloma in Relapse; Multiple Myeloma, RefractoryLast Updated:August 4, 2021Enrolling by invitation
196
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 1, 2022Recruiting
197
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:July 19, 2022Active, not recruiting
198
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:February 7, 2013Completed
199
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 2, 2016Unknown status
200
Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:October 11, 2013Completed